{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:16:50Z","timestamp":1777745810630,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40290-020-00359-4","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T08:02:32Z","timestamp":1603872152000},"page":"401-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plain Language Summaries of Clinical Trial Results: A Preliminary Study to Assess Availability of Easy-to-Understand Summaries and Approaches to Improving Public Engagement"],"prefix":"10.1007","volume":"34","author":[{"given":"Michael","family":"Penlington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajithkumar","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Pavithran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"issue":"7","key":"359_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/17512433.2019.1615441","volume":"12","author":"K Getz","year":"2019","unstructured":"Getz K, Farides-Mitchell J. Assessing the adoption of clinical trial results summary disclosure to patients and the public. Expert Rev Clin Pharmacol. 2019;12(7):573\u20138. https:\/\/doi.org\/10.1080\/17512433.2019.1615441(Accessed 24 Jun 2019).","journal-title":"Expert Rev Clin Pharmacol."},{"key":"359_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40290-019-00285-0","volume":"33","author":"A Barnes","year":"2019","unstructured":"Barnes A, Patrick S. Lay summaries of clinical study results: an overview. Pharm Med. 2019;33:261\u20138. https:\/\/doi.org\/10.1007\/s40290-019-00285-0.","journal-title":"Pharm Med."},{"key":"359_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJMsa1409364","volume":"372","author":"ML Anderson","year":"2015","unstructured":"Anderson ML, Chiswell K, Peterson ED, et al. Compliance with results reporting at clinicaltrials.gov. N Engl J Med. 2015;372:1031\u20139.","journal-title":"N Engl J Med."},{"key":"359_CR4","doi-asserted-by":"publisher","first-page":"k3218","DOI":"10.1136\/bmj.k3218","volume":"362","author":"B Goldacre","year":"2018","unstructured":"Goldacre B, DeVito NJ, et al. Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource. BMJ. 2018;362:k3218. https:\/\/doi.org\/10.1136\/bmj.k3218.","journal-title":"BMJ"},{"key":"359_CR5","unstructured":"Piller C. FDA and NIH let clinical trial sponsors keep results secret and break the law. https:\/\/www.sciencemag.org\/news\/2020\/01\/fda-and-nih-let-clinical-trial-sponsors-keep-results-secret-and-break-law?utm_campaign=news_daily_2020-01-13&et_rid=34822472&et_cid=3162276&utm_source=Global+Health+NOW+Main+List&utm_campaign=2f645daf7e-EMAIL_CAMPAIGN_2020_01_13_01_49&utm_medium=email&utm_term=0_8d0d062dbd-2f645daf7e-897391. Accessed 17 Aug 2020."},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40290-019-00284-1","volume":"33","author":"K Getz","year":"2019","unstructured":"Getz K. Reflections on the evolution of patient engagement in drug development. Pharm Med. 2019;33:179\u201385. https:\/\/doi.org\/10.1007\/s40290-019-00284-1.","journal-title":"Pharm Med."},{"key":"359_CR7","unstructured":"Anon. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. http:\/\/www.icmje.org\/icmje-recommendations.pdf. Accessed 17 Aug 2020."},{"key":"359_CR8","unstructured":"ClinicalTrials.gov PRS: Final rule (42 CFR Part 11) information. https:\/\/prsinfo.clinicaltrials.gov\/. Accessed 7 Sep 2020."},{"key":"359_CR9","unstructured":"Health Canada. Public release of clinical information regulation: guidance document. 2019. https:\/\/www.canada.ca\/en\/health-canada\/services\/drug-health-product-review-approval\/profile-public-release-clinical-information-guidance\/document.html. Accessed 8 Sep 2020."},{"key":"359_CR10","doi-asserted-by":"crossref","unstructured":"Shailes S. Plain-language Summaries of research: something for everyone. eLife. 2017;6:e25411. https:\/\/elifesciences.org\/articles\/25411.","DOI":"10.7554\/eLife.25411"},{"issue":"5","key":"359_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmjebm-2018-111145","volume":"24","author":"S Baronikova","year":"2019","unstructured":"Baronikova S, Purvis J, et al. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment. BMJ Evid-Based Med. 2019;24(5):177\u201384.","journal-title":"BMJ Evid-Based Med."},{"key":"359_CR12","unstructured":"CISCRP: 2019 Perceptions and insights study. https:\/\/www.ciscrp.org\/services\/research-services\/perceptions-and-insights-study\/. Accessed 4 Aug 2020."},{"key":"359_CR13","unstructured":"EFPIA\/EFCGP. Good lay summary practice. https:\/\/efgcp.eu\/documents\/GoodLaySummaryPractice_PublicConsultation199.pdf. Accessed 27 July 2020."},{"issue":"5","key":"359_CR14","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1371\/journal.pmed.0050091","volume":"5","author":"DI Shalowitz","year":"2008","unstructured":"Shalowitz DI, Miller FG. Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med. 2008;5(5):e91. https:\/\/doi.org\/10.1371\/journal.pmed.0050091.","journal-title":"PLoS Med."},{"issue":"6","key":"359_CR15","doi-asserted-by":"publisher","first-page":"e182969","DOI":"10.1001\/jamanetworkopen.2018.2969","volume":"1","author":"A Anderson","year":"2018","unstructured":"Anderson A, Borfitz D, Getz K. Global public attitudes about clinical research and patient experiences with clinical trials. JAMA Netw Open. 2018;1(6):e182969. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.2969.","journal-title":"JAMA Netw Open."},{"key":"359_CR16","unstructured":"Fierce Pharma. The top 20 pharma companies by 2019 revenue. 2020. https:\/\/www.fiercepharma.com\/special-report\/top-20-pharma-companies-by-2019-revenue Accessed 20 July 2020."},{"key":"359_CR17","unstructured":"TRS: Helping You Stay Informed. https:\/\/www.trialsummaries.com\/Home\/LandingPage Accessed 26 Aug 2020."},{"key":"359_CR18","unstructured":"CISCRP: https:\/\/www.ciscrp.org\/ Accessed 26 Aug 2020."},{"key":"359_CR19","unstructured":"Price C. 17 Great Search Engines You Can Use Instead of Google. https:\/\/www.searchenginejournal.com\/alternative-search-engines\/271409\/#close. Accessed 17 Aug 2020."},{"key":"359_CR20","unstructured":"Clinical Trials: What Patients Need to Know. https:\/\/www.fda.gov\/patients\/clinical-trials-what-patients-need-know. Accessed 26 Aug 2020."},{"key":"359_CR21","unstructured":"Grom T. Driving patient engagement. PharmaVOICE March 2020. https:\/\/www.pharmavoice.com\/article\/2020-03-patient-engagement\/ Accessed 17 Aug 2020."},{"key":"359_CR22","unstructured":"Getz, K.A. Measuring adoption and value of patient engagement. Appl Clin Trial. 2017;26(2):13\u201314. https:\/\/www.appliedclinicaltrialsonline.com\/view\/measuring-adoption-and-value-patient-engagement."}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-020-00359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40290-020-00359-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-020-00359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T05:05:21Z","timestamp":1608095121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40290-020-00359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s40290-020-00359-4","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"26 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The development of this manuscript and the open access fee was funded by GlaxoSmithKline.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors are full-time employees of and have shares in the GlaxoSmithKline group of companies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Coding was not used to identify study summaries either through search on web portals or through search engines.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed, critically reviewed drafts of the manuscript and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}